Laboratório de Proliferação e Diferenciação Celular, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
J Transl Med. 2019 Jul 31;17(1):247. doi: 10.1186/s12967-019-1998-9.
The molecular pathways that drive bone marrow myeloid progenitors (BMMP) development are very well understood and include a tight controlled multi-stage gene hierarch. Monocytes are versatile cells that display remarkable plasticity and may give rise to specific subsets of macrophages to proper promote tissue homesostasis upon an injury. However, the epigenetic mechanisms that underlie monocyte differentiation into the pro-inflammatory Ly6C or the repairing Ly6C subsets are yet to be elucidated. We have previously shown that Epigenetic mechanisms Histone Deacetylase (HDAC) dependent are crucial for monocyte behavior and plasticity and in this work, we propose that this same mechanism underlies BMMP plasticity upon an inflammatory challenge in vivo.
BMMP were culture in the presence of GM-CSF alone or in combination with HDAC inhibitor (iHDAC) and phenotyped by flow cytometry, immune staining or western blot. iHDAC was topically added to skin wounds for 7 consecutive days and wound healing was monitored by flow cytometry and histopathological analysis.
When BMMP were cultured in the presence of iHDAC, we showed that the CD11b/Ly6C subset was the specific target of iHDAC that underwent chromatin hyperacetylation in vitro. Upon 13 days in the presence of iHDAC, BMMP gave rise to very elongated macrophages, that in turn, displayed a remarkable plasticity in a HDAC activity dependent fashion. HDAC-dependent cell shape was tight related to macrophage behavior and phenotype through the control of iNOS protein levels, showing that chromatin remodeling is a key component of macrophage plasticity and function. We then hypothesized that iHDAC would modulate the inflammatory response and favor tissue repair in vivo. To test this hypothesis, we topically added iHDAC to skin wounds during 7 consecutive days and followed tissue repair dynamics. In fact, iHDAC treated skin wounds presented an increase in wound closure at day 5 that was correlated to an enrichment in the CD11b/Ly6C subset and in very elongated F4/80 positives macrophages in vivo, fully recapitulating the behavior previously observed in vitro.
Our work provides the biological basis that connects chromatin remodeling to phenotypic plasticity, which in turn, may become a tractable therapeutic strategy in further translational studies.
驱动骨髓髓系祖细胞(BMMP)发育的分子途径已得到很好的理解,包括一个紧密控制的多阶段基因层次。单核细胞是多功能细胞,具有显著的可塑性,可以产生特定的巨噬细胞亚群,以在损伤后适当促进组织稳态。然而,单核细胞分化为促炎 Ly6C 或修复 Ly6C 亚群的表观遗传机制尚待阐明。我们之前已经表明,组蛋白去乙酰化酶(HDAC)依赖性表观遗传机制对于单核细胞的行为和可塑性至关重要,在这项工作中,我们提出,在体内炎症挑战下,正是这种相同的机制构成了 BMMP 的可塑性。
BMMP 在 GM-CSF 单独存在或与 HDAC 抑制剂(iHDAC)组合的情况下进行培养,并通过流式细胞术、免疫染色或 Western blot 进行表型分析。iHDAC 连续 7 天局部添加到皮肤伤口中,并通过流式细胞术和组织病理学分析监测伤口愈合情况。
当 BMMP 在 iHDAC 的存在下培养时,我们表明 CD11b/Ly6C 亚群是 iHDAC 的特定靶点,其在体外经历染色质超乙酰化。在存在 iHDAC 的 13 天内,BMMP 产生了非常长的巨噬细胞,这些巨噬细胞反过来以 HDAC 活性依赖性的方式表现出显著的可塑性。HDAC 依赖性细胞形状与巨噬细胞行为和表型密切相关,通过控制 iNOS 蛋白水平,表明染色质重塑是巨噬细胞可塑性和功能的关键组成部分。然后,我们假设 iHDAC 将调节炎症反应并有利于体内组织修复。为了验证这一假设,我们在连续 7 天内将 iHDAC 局部添加到皮肤伤口中,并跟踪组织修复动力学。事实上,iHDAC 处理的皮肤伤口在第 5 天的伤口闭合率增加,这与体内 CD11b/Ly6C 亚群和非常长的 F4/80 阳性巨噬细胞的富集相关,完全再现了之前在体外观察到的行为。
我们的工作提供了将染色质重塑与表型可塑性联系起来的生物学基础,这反过来又可能成为进一步转化研究中的一种可行的治疗策略。